Pubblicazioni di riferimento
Hurley JR 2000 Management of thyroid cancer: radioiodine ablation, “stunning”, and treatment of thyroglobulinpositive, (131)I scan-negative patients. Endocr Pract 6: 401–406.
Lee J, Yun MJ, Nam KH, Chung WY, Soh EY, Park CS 2010 Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma. Thyroid 20: 173–179.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Schlumberger, M., Catargi, B., Borget, I. et al. Strategie per l’ablazione con radioiodio nei pazienti con carcinoma tiroideo a basso rischio. L’Endocrinologo 13, 276 (2012). https://doi.org/10.1007/BF03346019
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346019